This webinar was on Sept. 21. Watch the recording now!

About

Learn about the current recommendations surrounding COVID-19 and immunocompromised individuals in this presentation by Dr. Miskulin.

Dana Miskulin, MD

Speaker

Dr. Miskulin is a nephrologist at Tufts Medical Center, Boston MA. She sees patients in the ADPKD Specialty Clinic and serves as an investigator for clinical trials in ADPKD at the Tufts MC site.

Learning objective(s):

  • Understand the implications of the Delta variant of COVID.
  • Learn precautions needed against the Delta variant of COVID.
  • Discuss the current CDC recommendations regarding COVID and immunocompromised individuals.

Related Resources

Manual para pacientes con ERPAD: Entender y vivir con la enfermedad renal poliquística autosómica dominante

Manual para pacientes con ERPAD: Entender y vivir con la enfermedad renal poliquística autosómica dominante

El propósito de este manual es proporcionar información sobre la enfermedad renal poliquística autosómica dominante (ERPAD). Será un documento útil para aquellas personas que tienen la enfermedad, para las que tienen riesgo de tenerla debido a un progenitor afectado, así como para los familiares y amigos involucrados. No está dirigido a los pacientes con enfermedad renal poliquística autosómica recesiva (ERPAR). Para los pacientes con esta enfermedad, hay un manual disponible en pkdcure.org. En lo sucesivo, nos referiremos a la ERPAD simplemente como ERP.

KETO-PKD Study

KETO-PKD Study

Tuesday, December 1, 2021 | 11 a.m. CST

Dr. Roman-Ulrich Müller of University Hospital Cologne gives an update on the KETO-PKD Study (begun Oct. 2020).

Understanding Lab Results

Understanding Lab Results

Tuesday, November 16, 2021 | 7 p.m. CDT

Labs provide you and your doctor with valuable information about your overall health and your kidney function. It is important to understand the labs that your doctor requests, track your results, and know when specific labs are or are not within the normal range.